[BKAWAN] QoQ Annualized Quarter Result on 30-Sep-2021 [#4]

Announcement Date
23-Nov-2021
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2021
Quarter
30-Sep-2021 [#4]
Profit Trend
QoQ- 2.54%
YoY- 174.86%
View:
Show?
Annualized Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 28,007,088 27,510,928 28,403,544 20,717,928 19,415,096 18,324,018 17,744,260 35.67%
PBT 3,585,701 3,763,526 4,083,920 3,086,006 2,925,856 2,430,640 2,099,800 43.00%
Tax -860,480 -974,656 -1,185,532 -546,422 -484,197 -460,494 -370,040 75.79%
NP 2,725,221 2,788,870 2,898,388 2,539,584 2,441,658 1,970,146 1,729,760 35.51%
-
NP to SH 1,268,748 1,294,530 1,322,916 1,146,934 1,118,529 904,864 765,404 40.19%
-
Tax Rate 24.00% 25.90% 29.03% 17.71% 16.55% 18.95% 17.62% -
Total Cost 25,281,866 24,722,058 25,505,156 18,178,344 16,973,437 16,353,872 16,014,500 35.69%
-
Net Worth 7,304,576 7,124,395 6,671,755 6,352,653 6,445,602 6,164,034 5,966,635 14.48%
Dividend
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Div 105,081 157,699 - 79,205 105,693 158,662 - -
Div Payout % 8.28% 12.18% - 6.91% 9.45% 17.53% - -
Equity
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Net Worth 7,304,576 7,124,395 6,671,755 6,352,653 6,445,602 6,164,034 5,966,635 14.48%
NOSH 443,665 443,665 443,665 443,665 443,665 443,665 443,665 0.00%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin 9.73% 10.14% 10.20% 12.26% 12.58% 10.75% 9.75% -
ROE 17.37% 18.17% 19.83% 18.05% 17.35% 14.68% 12.83% -
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 7,107.39 6,978.06 7,200.98 5,231.46 4,898.47 4,619.62 4,466.82 36.40%
EPS 321.97 328.36 335.40 289.61 282.21 228.12 192.80 40.88%
DPS 26.67 40.00 0.00 20.00 26.67 40.00 0.00 -
NAPS 18.5369 18.0708 16.9145 16.041 16.2624 15.54 15.02 15.10%
Adjusted Per Share Value based on latest NOSH - 443,665
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
RPS 6,312.65 6,200.82 6,402.01 4,669.71 4,376.06 4,130.14 3,999.46 35.67%
EPS 285.97 291.78 298.18 258.51 252.11 203.95 172.52 40.19%
DPS 23.68 35.54 0.00 17.85 23.82 35.76 0.00 -
NAPS 16.4641 16.058 15.0378 14.3186 14.5281 13.8934 13.4485 14.48%
Price Multiplier on Financial Quarter End Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 -
Price 23.08 26.30 22.70 20.80 19.40 17.80 17.90 -
P/RPS 0.32 0.38 0.32 0.40 0.40 0.39 0.40 -13.85%
P/EPS 7.17 8.01 6.77 7.18 6.87 7.80 9.29 -15.89%
EY 13.95 12.48 14.77 13.92 14.55 12.82 10.76 18.95%
DY 1.16 1.52 0.00 0.96 1.37 2.25 0.00 -
P/NAPS 1.25 1.46 1.34 1.30 1.19 1.15 1.19 3.34%
Price Multiplier on Announcement Date
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Date 17/08/22 24/05/22 16/02/22 23/11/21 18/08/21 19/05/21 25/02/21 -
Price 23.98 27.50 25.74 21.90 20.10 19.00 17.50 -
P/RPS 0.34 0.39 0.36 0.42 0.41 0.41 0.39 -8.76%
P/EPS 7.45 8.38 7.67 7.56 7.12 8.33 9.08 -12.38%
EY 13.43 11.94 13.03 13.22 14.04 12.01 11.01 14.20%
DY 1.11 1.45 0.00 0.91 1.33 2.11 0.00 -
P/NAPS 1.29 1.52 1.52 1.37 1.24 1.22 1.17 6.74%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment